Literature DB >> 7524312

The use of oral fluid for hepatitis C antibody screening.

K E Sherman1, R L Creager, J O'Brien, S Sargent, S Piacentini, T Thieme.   

Abstract

OBJECTIVES: To assess the efficacy of oral fluid antibody testing for the detection of hepatitis C.
METHODS: Paired serum and oral fluid collections were obtained from 216 subjects. A modification of the serum HCV ELISA assay was developed to improve test accuracy for an oral fluid substrate. Sensitivity was determined in 109 HCV serum ELISA-positive patients and specificity in 107 HCV serum ELISA-negative patients.
RESULTS: Overall sensitivity of oral fluid collection and testing was 98.2%; specificity was 99.1%. These parameters did not seem to be altered by presence of concurrent hepatitis B infection, inflammatory state of the liver, or other factors.
CONCLUSIONS: Oral fluid collection and HCV antibody testing by the modified ELISA method seems to be an effective and efficient alternatives to venipuncture and serum HCV antibody testing. Their use may facilitate epidemiological surveys and evaluation of individual patients when blood collection is not feasible.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524312

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Recognition of multiple classes of hepatitis C antibodies increases detection sensitivity in oral fluid.

Authors:  J F Zmuda; B Wagoneer; L Liotta; G Whiteley
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

2.  Correlation between detection of antibodies against hepatitis C virus in oral fluid and hepatitis C virus RNA in serum.

Authors:  L Cock De; V Hutse; R Vranckx
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  Modified enzyme immunoassay to detect hepatitis C virus antibodies in oral fluid.

Authors:  P G McIntyre; J Laszlo; K Appleyard; G R Ogden
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-11       Impact factor: 3.267

Review 4.  Detecting viruses by using salivary diagnostics.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  J Am Dent Assoc       Date:  2012-10       Impact factor: 3.634

5.  Assessment of a hepatitis C virus antibody assay in saliva for epidemiological studies.

Authors:  P Y Bello; C Pasquier; P Gourney; J Puel; J Izopet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

6.  Importance of collection methods and stability of oral fluid samples for hepatitis B surface antigen detection.

Authors:  Letícia de Paula Scalioni; Helena Medina Cruz; Vanessa Salete de Paula; Jaqueline Corrêia Oliveira; Renata Tourinho Dos Santos; Ana Rita Coimbra Motta-Castro; Paula Guerra Murat; Cristiane Alves Villela-Nogueira; Lia Laura Lewis-Ximenez; Elisabeth Lampe; Livia Melo Villar
Journal:  J Clin Lab Anal       Date:  2013-02-25       Impact factor: 2.352

7.  Detection of proviral human T-cell lymphotrophic virus type I DNA in mouthwash samples of HAM/TSP patients and HTLV-I carriers.

Authors:  A Achiron; O Pinhas-Hamiel; Y Barak; L Doll; D Offen; R Djaldetti; G Frankel; B Shohat
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

8.  Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies.

Authors:  V González; E Martró; C Folch; A Esteve; L Matas; A Montoliu; J R Grífols; F Bolao; C Tural; R Muga; J V Parry; V Ausina; J Casabona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-11-20       Impact factor: 3.267

9.  A novel point-of-care oral anti-HCV assay: Is it reliable for screening hepatitis C virus infection in the era of direct-acting antivirals?

Authors:  Rui-Feng Yang; Yan Liu; Cai-Yan Zhao; Ya-Xing Ding; Yu Chen; Ya-Dong Wang; Zhong-Ping Duan
Journal:  PLoS One       Date:  2019-02-12       Impact factor: 3.240

10.  SARS-CoV-2 Specific IgG Antibodies Persist Over a 12-Month Period in Oral Mucosal Fluid Collected From Previously Infected Individuals.

Authors:  Prithivi Chellamuthu; Aaron N Angel; Melanie A MacMullan; Nicholas Denny; Aubree Mades; Marilisa Santacruz; Ronell Lopez; Cedie Bagos; Joseph G Casian; Kylie Trettner; Lauren Lopez; Nina Nirema; Matthew Brobeck; Noah Kojima; Jeffrey D Klausner; Fred Turner; Vladimir Slepnev; Albina Ibrayeva
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.